Metamizole

Orphan designation: Human monoclonal IgG1 antibody against tissue factor pathway inhibitor Treatment of haemophilia A, 14/10/2016 Withdrawn

Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tavlesse, fostamatinib, Date of authorisation: 09/01/2020, Revision: 6, Status: Authorised

Tavlesse : EPAR - Risk management plan

PSUSA/00002204/202404

Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 3, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Prevexxion RN+HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Metacam, meloxicam, Status: Authorised

Human medicines European public assessment report (EPAR): Sancuso, granisetron, Date of authorisation: 20/04/2012, Revision: 15, Status: Authorised